GE HealthCare Technologies Inc. $GEHC Stock Sold by Keybank National Association OH

Keybank National Association OH lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 48.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 136,739 shares of the company’s stock after selling 126,280 shares during the period. Keybank National Association OH’s holdings in GE HealthCare Technologies were worth $8,939,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of GEHC. State Street Corp boosted its stake in shares of GE HealthCare Technologies by 1.6% during the 2nd quarter. State Street Corp now owns 20,861,566 shares of the company’s stock worth $1,335,349,000 after acquiring an additional 323,090 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its position in shares of GE HealthCare Technologies by 13.2% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after purchasing an additional 1,571,226 shares during the period. Dimensional Fund Advisors LP raised its position in shares of GE HealthCare Technologies by 2.0% during the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after purchasing an additional 105,995 shares during the period. Van ECK Associates Corp raised its position in shares of GE HealthCare Technologies by 4.1% during the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after purchasing an additional 177,028 shares during the period. Finally, Mizuho Markets Cayman LP raised its position in shares of GE HealthCare Technologies by 173.2% during the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company’s stock worth $218,416,000 after purchasing an additional 1,945,500 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $81.84 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.01 and a current ratio of 1.30. The stock has a market cap of $37.00 billion, a P/E ratio of 17.27, a P/E/G ratio of 2.08 and a beta of 0.65. The firm has a 50 day simple moving average of $70.29 and a 200 day simple moving average of $70.10. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.14. The firm had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The company’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.07 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a dividend of $0.04 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio is presently 3.38%.

Analyst Upgrades and Downgrades

GEHC has been the subject of several analyst reports. Barclays upped their target price on GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, October 29th. Oppenheimer reissued an “outperform” rating on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Evercore restated an “outperform” rating and set a $84.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Finally, Royal Bank Of Canada upped their price objective on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, October 29th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $82.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.